Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 2
1963 3
1964 5
1965 1
1966 2
1967 2
1968 3
1969 8
1970 2
1971 4
1972 4
1973 2
1974 3
1975 3
1976 6
1977 6
1978 4
1979 5
1980 6
1981 10
1982 10
1983 14
1984 16
1985 12
1986 23
1987 10
1988 20
1989 21
1990 30
1991 23
1992 29
1993 37
1994 30
1995 22
1996 36
1997 42
1998 37
1999 39
2000 50
2001 52
2002 65
2003 49
2004 44
2005 53
2006 49
2007 43
2008 41
2009 49
2010 44
2011 62
2012 64
2013 60
2014 59
2015 78
2016 66
2017 80
2018 86
2019 84
2020 102
2021 100
2022 98
2023 98
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

1,914 results

Results by year

Filters applied: . Clear all
Page 1
Engineered skin bacteria induce antitumor T cell responses against melanoma.
Chen YE, Bousbaine D, Veinbachs A, Atabakhsh K, Dimas A, Yu VK, Zhao A, Enright NJ, Nagashima K, Belkaid Y, Fischbach MA. Chen YE, et al. Among authors: nagashima k. Science. 2023 Apr 14;380(6641):203-210. doi: 10.1126/science.abp9563. Epub 2023 Apr 13. Science. 2023. PMID: 37053311
Design, construction, and in vivo augmentation of a complex gut microbiome.
Cheng AG, Ho PY, Aranda-Díaz A, Jain S, Yu FB, Meng X, Wang M, Iakiviak M, Nagashima K, Zhao A, Murugkar P, Patil A, Atabakhsh K, Weakley A, Yan J, Brumbaugh AR, Higginbottom S, Dimas A, Shiver AL, Deutschbauer A, Neff N, Sonnenburg JL, Huang KC, Fischbach MA. Cheng AG, et al. Among authors: nagashima k. Cell. 2022 Sep 15;185(19):3617-3636.e19. doi: 10.1016/j.cell.2022.08.003. Epub 2022 Sep 6. Cell. 2022. PMID: 36070752 Free PMC article.
Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation.
Le Floc'h A, Allinne J, Nagashima K, Scott G, Birchard D, Asrat S, Bai Y, Lim WK, Martin J, Huang T, Potocky TB, Kim JH, Rafique A, Papadopoulos NJ, Stahl N, Yancopoulos GD, Murphy AJ, Sleeman MA, Orengo JM. Le Floc'h A, et al. Among authors: nagashima k. Allergy. 2020 May;75(5):1188-1204. doi: 10.1111/all.14151. Epub 2020 Jan 3. Allergy. 2020. PMID: 31838750 Free PMC article.
Mapping the T cell repertoire to a complex gut bacterial community.
Nagashima K, Zhao A, Atabakhsh K, Bae M, Blum JE, Weakley A, Jain S, Meng X, Cheng AG, Wang M, Higginbottom S, Dimas A, Murugkar P, Sattely ES, Moon JJ, Balskus EP, Fischbach MA. Nagashima K, et al. Nature. 2023 Sep;621(7977):162-170. doi: 10.1038/s41586-023-06431-8. Epub 2023 Aug 16. Nature. 2023. PMID: 37587342
Thermal comfort.
Nagashima K, Tokizawa K, Marui S. Nagashima K, et al. Handb Clin Neurol. 2018;156:249-260. doi: 10.1016/B978-0-444-63912-7.00015-1. Handb Clin Neurol. 2018. PMID: 30454593 Review.
A troubling tachycardia.
Hayashida S, Nagashima K, Iso K, Okumura Y, Scheinman MM. Hayashida S, et al. Among authors: nagashima k. Heart Rhythm. 2022 Jun;19(6):1031-1032. doi: 10.1016/j.hrthm.2021.09.001. Heart Rhythm. 2022. PMID: 35636839 No abstract available.
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.
Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group. Misawa S, et al. Among authors: nagashima k. Lancet Neurol. 2018 Jun;17(6):519-529. doi: 10.1016/S1474-4422(18)30114-5. Epub 2018 Apr 21. Lancet Neurol. 2018. PMID: 29685815 Clinical Trial.
Novel Diagnostic Observations of Nodoventricular/Nodofascicular Pathway-Related Orthodromic Reciprocating Tachycardia Differentiating From Atrioventricular Nodal Re-Entrant Tachycardia.
Nagashima K, Kaneko Y, Maruyama M, Nogami A, Kowase S, Mori H, Sumitomo N, Fukamizu S, Hojo R, Kitamura T, Soejima K, Ueda A, Otsuka T, Takami M, Tanimoto K, Asakawa T, Kumagai K, Tamura S, Hasegawa H, Ogura K, Kawamura M, Munetsugu Y, Shoda M, Higuchi S, Kanazawa H, Kusa S, Mizukami A, Miyazaki S, Wakamatsu Y, Okumura Y. Nagashima K, et al. JACC Clin Electrophysiol. 2020 Dec;6(14):1797-1807. doi: 10.1016/j.jacep.2020.07.007. Epub 2020 Sep 30. JACC Clin Electrophysiol. 2020. PMID: 33357576 Free article.
Strain dropouts reveal interactions that govern the metabolic output of the gut microbiome.
Wang M, Osborn LJ, Jain S, Meng X, Weakley A, Yan J, Massey WJ, Varadharajan V, Horak A, Banerjee R, Allende DS, Chan ER, Hajjar AM, Wang Z, Dimas A, Zhao A, Nagashima K, Cheng AG, Higginbottom S, Hazen SL, Brown JM, Fischbach MA. Wang M, et al. Among authors: nagashima k. Cell. 2023 Jun 22;186(13):2839-2852.e21. doi: 10.1016/j.cell.2023.05.037. Cell. 2023. PMID: 37352836
Blocking common γ chain cytokine signaling ameliorates T cell-mediated pathogenesis in disease models.
Le Floc'h A, Nagashima K, Birchard D, Scott G, Ben LH, Ajithdoss D, Gayvert K, Romero Hernandez A, Herbin O, Tay A, Farrales P, Korgaonkar CK, Pan H, Shah S, Kamat V, Chatterjee I, Popke J, Oyejide A, Lim WK, Kim JH, Huang T, Franklin M, Olson W, Norton T, Perlee L, Yancopoulos GD, Murphy AJ, Sleeman MA, Orengo JM. Le Floc'h A, et al. Among authors: nagashima k. Sci Transl Med. 2023 Jan 11;15(678):eabo0205. doi: 10.1126/scitranslmed.abo0205. Epub 2023 Jan 11. Sci Transl Med. 2023. PMID: 36630481
1,914 results